Elizabeth Hutt Pollard
Expertise: Bringing highly specialized products to market and scaling businesses
Elizabeth is Chair of the Board of Directors and Applied Silver’s strategic and operational leader. She manages the board and investors, overall company strategy, operations, and corporate development. Elizabeth has extensive experience in commercializing highly specialized genomic and healthcare-related products. She is a C-Suite veteran and has extensive experience bringing to market highly specialized technology and solutions for healthcare. She currently serves as a strategic advisor to several early-stage life science companies and holds leadership positions in YPO, the premier leadership organization of chief executives in the world. Prior to joining Applied Silver, Elizabeth was CEO of NuGEN Technologies, a global leader in genomic sample preparation products enabling scientists and clinicians to discover genetic signatures and predict disease risk and drug response, potentially shortening the path to treatment. Elizabeth has also held US and International management roles with Tripos, Affymetrix, and Life Technologies, during significant growth phases of these life science businesses. Elizabeth spent three years as a research associate at the University of Michigan in the Departments of Hematology/Oncology, where she made the decision to have a broader impact on medical research by transitioning into a career within the commercial biotechnology sector. She holds a B.A. in Chemistry from Michigan State University and an M.S. in Administration from Central Michigan University.